1. |
Wang X, Sun G, Yi Z. Leakage index on ultra-widefield fluorescence angiography in different regions of retina and its correlation with cystoid macular edema in central retinal vein occlusion eyes[J]. Graefe's Arch Clin Exp Ophthalmol, 2021, 259(8): 2149-2156. DOI: 10.1007/s00417-021-05126-y.
|
2. |
谷去非, 母林华. 葡萄膜炎42例眼底荧光造影特征分析[J]. 中国现代医药杂志, 2007, 9(6): 12. DOI: 10.3969/j.issn.1672-9463.2007.06.036.Gu QF, Mu LH. Analysis of the characteristics of fundus fluorescein angiography in 42 cases of uveitis[J]. Modern Medicine Journal of China, 2007, 9(6): 12. DOI: 10.3969/j.issn.1672-9463.2007.06.036.
|
3. |
Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified airlie house classification. ETDRS report number 10[J]. Ophthalmology, 1991, 98(5 Suppl): S786-806.
|
4. |
Tsui I, Kaines A, Havunjian MA, et al. Ischemic index and neovascularization in central retinal vein occlusion[J]. Retina, 2011, 31(1): 105-110. DOI: 10.1097/IAE.0b013e3181e36c6d.
|
5. |
Prasad PS, Oliver SC, Coffee RE, et al. Ultra wide-field angiographic characteristics of branch retinal and hemicentral retinal vein occlusion[J]. Ophthalmology, 2010, 117(4): 780-784. DOI: 10.1016/j.ophtha.2009.09.019.
|
6. |
Wessel MM, Aaker GD, Parlitsis G, et al. Ultra-wide-field angiography improves the detection and classification of diabetic retinopathy[J]. Retina, 2012, 32(4): 785-791. DOI: 10.1097/IAE.0b013e3182278b64.
|
7. |
Karampelas M, Sim DA, Chu C, et al. Quantitative analysis of peripheral vasculitis, ischemia, and vascular leakage in uveitis using ultra-widefield fluorescein angiography[J]. Am J Ophthalmol, 2015, 159(6): 1161-1168. DOI: 10.1016/j.ajo.2015.02.009.
|
8. |
陈长征, 王晓玲. 正确分析周边部视网膜超广角荧光素眼底血管造影特征[J]. 中华实验眼科杂志, 2020, 38(7): 562-565. DOI: 10.3760/cma.j.cn115989-20190401-00158.Chen CZ, Wang XL. To correctly analyze ultra-wide field fluorescein angiography in peripheral retina[J]. Chin J Exp Ophthalmol, 2020, 38(7): 562-565. DOI: 10.3760/cma.j.cn115989-20190401-00158.
|
9. |
Quinn N, Csincsik L, Flynn E, et al. The clinical relevance of visualising the peripheral retina[J]. Prog Retin Eye Res, 2019, 68: 83-109. DOI: 10.1016/j.preteyeres.2018.10.001.
|
10. |
Bhagat N, Grigorian RA, Tutela A, et al. Diabetic macular edema: pathogenesis and treatment[J]. Surv Ophthalmol, 2009, 54(1): 1-32. DOI: 10.1016/j.survophthal.2008.10.001.
|
11. |
Ehlers JP, Jiang AC, Boss JD, et al. Quantitative ultra-widefield angiography and diabetic retinopathy severity[J]. Ophthalmology, 2019, 126(11): 1527-1532. DOI: 10.1016/j.ophtha.2019.05.034.
|
12. |
ValdezGuerrero AS, Quintana-Pérez JC, Arellano-Mendoza MG, et al. Diabetic retinopathy: important biochemical alterations and the main treatment strategies[J]. Can J Diabetes, 2021, 45(6): 504-511. DOI: 10.1016/j.jcjd.2020.10.009.
|
13. |
Mitry D, Bunce C, Charteris D. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion[J/OL]. Cochrane Database Syst Rev, 2013(1): D9510[2013-01-31]. https://pubmed.ncbi.nlm.nih.gov/23440840/. DOI: 10.1002/14651858.CD009510.pub2.
|
14. |
许阿敏, 陈长征, 易佐慧子, 等. 糖尿病视网膜病变超广角荧光素眼底血管造影检查与标准7视野检查结果的对比分析[J]. 中华眼底病杂志, 2017, 33(1): 23-26. DOI: 10.3760/cma.j.issn.1005-1015.2017.01.007.Xu AM, Chen CZ, Yi ZHZ, et al. Comparative analysis of ultra-wide-field fluorescein angiography and early treatment diabetic retinopathy study 7 standard field photography in diabetic retinopathy[J]. Chin J Ocul Fundus Dis, 2017, 33(1): 23-26. DOI: 10.3760/cma.j.issn.1005-1015.2017.01.007.
|
15. |
Thomas AS, Thomas MK, Finn AP, et al. Use of the ischemic index on widefield fluorescein angiography to characterize a central retinal vein occlusion as ischemic or nonischemic[J]. Retina, 2019, 39(6): 1033-1038. DOI: 10.1097/IAE.0000000000002126.
|
16. |
Price LD, Au S, Chong NV. Optomap ultrawide field imaging identifies additional retinal abnormalities in patients with diabetic retinopathy[J]. Clin Ophthalmol, 2015, 9: 527-531. DOI: 10.2147/OPTH.S79448.
|
17. |
Oliver SC, Schwartz SD. Peripheral vessel leakage (PVL): a new angiographic finding in diabetic retinopathy identified with ultra wide-field fluorescein angiography[J]. Semin Ophthalmol, 2010, 25(1-2): 27-33. DOI: 10.3109/08820538.2010.481239.
|
18. |
Sim DA, Keane PA, Rajendram R, et al. Patterns of peripheral retinal and central macula ischemia in diabetic retinopathy as evaluated by ultra-widefield fluorescein angiography[J]. Am J Ophthalmol, 2014, 158(1): 144-153. DOI: 10.1016/j.ajo.2014.03.009.
|
19. |
Singer M, Sagong M, van Hemert J, et al. Ultra-widefield imaging of the peripheral retinal vasculature in normal subjects[J]. Ophthalmology, 2016, 123(5): 1053-1059. DOI: 10.1016/j.ophtha.2016.01.022.
|
20. |
Ehlers JP, Wang K, Vasanji A, et al. Automated quantitative characterisation of retinal vascular leakage and microaneurysms in ultra-widefield fluorescein angiography[J]. Br J Ophthalmol, 2017, 101(6): 696-699. DOI: 10.1136/bjophthalmol-2016-310047.
|
21. |
Silva PS, Dela CA, Ledesma MG, et al. Diabetic retinopathy severity and peripheral lesions are associated with nonperfusion on ultrawide field angiography[J]. Ophthalmology, 2015, 122(12): 2465-2472. DOI: 10.1016/j.ophtha.2015.07.034.
|
22. |
Hajdu D, Sedova A, Datlinger F, et al. Association of macular perfusion status with microvascular parameters up to the far periphery in diabetic retinopathy using multimodal imaging[J]. Int J Retina Vitreous, 2020, 6(1): 50. DOI: 10.1186/s40942-020-00253-w.
|
23. |
Hariprasad SM, Mieler WF, Grassi M, et al. Vision-related quality of life in patients with diabetic macular oedema[J]. Br J Ophthalmol, 2008, 92(1): 89-92. DOI: 10.1136/bjo.2007.122416.
|
24. |
Jiang AC, Srivastava SK, Hu M, et al. Quantitative ultra-widefield angiographic features and associations with diabetic macular edema[J]. Ophthalmol Retina, 2020, 4(1): 49-56. DOI: 10.1016/j.oret.2019.08.008.
|
25. |
Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema: results from 2 phase Ⅲ randomized trials: RISE and RIDE[J]. Ophthalmology, 2012, 119(4): 789-801. DOI: 10.1016/j.ophtha.2011.12.039.
|
26. |
Bonnin S, Dupas B, Lavia C, et al. Anti-vascular endothelial growth factor therapy can improve diabetic retinopathy score without change in retinal perfusion[J]. Retina, 2019, 39(3): 426-434. DOI: 10.1097/IAE.0000000000002422.
|
27. |
Bressler SB, Liu D, Glassman AR, et al. Change in diabetic retinopathy through 2 years: secondary analysis of a randomized clinical trial comparing aflibercept, bevacizumab, and ranibizumab[J]. JAMA Ophthalmol, 2017, 135(6): 558-568. DOI: 10.1001/jamaophthalmol.2017.0821.
|
28. |
Chandra S, Sheth J, Anantharaman G, et al. Ranibizumab-induced retinal reperfusion and regression of neovascularization in diabetic retinopathy: an angiographic illustration[J]. Am J Ophthalmol Case Rep, 2018, 9: 41-44. DOI: 10.1016/j.ajoc.2018.01.006.
|
29. |
Gupta MP, Kiss S, Chan R. Reversal of retinal vascular leakage and arrest of progressive retinal nonperfusion with monthly anti-vascular endothelial growth factor therapy for proliferative diabetic retinopathy[J/OL]. Retina, 2018, 38(9): e74-e75[2018-09-01]. https://pubmed.ncbi.nlm.nih.gov/30005003/. DOI: 10.1097/IAE.0000000000002261.
|
30. |
Levin AM, Rusu I, Orlin A, et al. Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections[J]. Clin Ophthalmol, 2017, 11: 193-200. DOI: 10.2147/OPTH.S118807.
|
31. |
Allingham MJ, Mukherjee D, Lally EB, et al. A quantitative approach to predict differential effects of anti-VEGF treatment on diffuse and focal leakage in patients with diabetic macular edema: a pilot study[J]. Transl Vis Sci Technol, 2017, 6(2): 7. DOI: 10.1167/tvst.6.2.7.
|
32. |
Babiuch AS, Wykoff CC, Srivastava SK, et al. Retinal leakage index dynamics on ultra-widefield fluorescein angiography in eyes treated with intravitreal aflibercept for proliferative diabetic retinopathy in the recovery study[J]. Retina, 2020, 40(11): 2175-2183. DOI: 10.1097/IAE.0000000000002727.
|
33. |
Yu HJ, Ehlers JP, Sevgi DD, et al. Real-time photographic- and fluorescein angiographic-guided management of diabetic retinopathy: randomized prime trial outcomes[J]. Am J Ophthalmol, 2021, 226: 126-136. DOI: 10.1016/j.ajo.2021.01.024.
|
34. |
McIntosh RL, Rogers SL, Lim L, et al. Natural history of central retinal vein occlusion: an evidence-based systematic review[J]. Ophthalmology, 2010, 117(6): 1113-1123. DOI: 10.1016/j.ophtha.2010.01.060.
|
35. |
Hayreh SS, Podhajsky PA, Zimmerman MB. Natural history of visual outcome in central retinal vein occlusion[J]. Ophthalmology, 2011, 118(1): 119-133. DOI: 10.1016/j.ophtha.2010.04.019.
|
36. |
Manivannan A, Plskova J, Farrow A, et al. Ultra-wide-field fluorescein angiography of the ocular fundus[J]. Am J Ophthalmol, 2005, 140(3): 525-527. DOI: 10.1016/j.ajo.2005.02.055.
|
37. |
Campbell JP, Leder HA, Sepah YJ, et al. Wide-field retinal imaging in the management of noninfectious posterior uveitis[J]. Am J Ophthalmol, 2012, 154(5): 908-911. DOI: 10.1016/j.ajo.2012.05.019.
|
38. |
Fang M, Fan W, Shi Y, et al. Classification of regions of nonperfusion on ultra-widefield fluorescein angiography in patients with diabetic macular edema[J]. Am J Ophthalmol, 2019, 206: 74-81. DOI: 10.1016/j.ajo.2019.03.030.
|
39. |
Rabiolo A, Cicinelli MV, Corbelli E, et al. Correlation analysis between foveal avascular zone and peripheral ischemic index in diabetic retinopathy: a pilot study[J]. Ophthalmol Retina, 2018, 2(1): 46-52. DOI: 10.1016/j.oret.2017.05.007.
|
40. |
Sakimoto S, Kamei M, Suzuki M, et al. Relationship between grades of macular perfusion and foveal thickness in branch retinal vein occlusion[J]. Clin Ophthalmol, 2013, 7: 39-45. DOI: 10.2147/OPTH.S37185.
|